Details
| Stereochemistry | UNKNOWN |
| Molecular Formula | C9H14N4O |
| Molecular Weight | 194.2337 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 0 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)(N1CC1C#N)N2CC2C(N)=O
InChI
InChIKey=RPZOFMHRRHHDPZ-UHFFFAOYSA-N
InChI=1S/C9H14N4O/c1-9(2,12-4-6(12)3-10)13-5-7(13)8(11)14/h6-7H,4-5H2,1-2H3,(H2,11,14)
| Molecular Formula | C9H14N4O |
| Molecular Weight | 194.2337 |
| Charge | 0 |
| Count |
|
| Stereochemistry | MIXED |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Azimexon, a synthetic derivative of the 2-cyanaziridines, possesses the immunorestorative properties that were shown for patients with acquired immunodeficiency syndrome. Besides, azimexon had a role in managing cancer-associated dysregulation of the immune response. It was studied in clinical trials phase I to determine the drug's tolerable dose, toxicity, and effects on immune and nonimmune host defense parameters.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Animal experiments on the compensation of the immunosuppressive action of cyclophosphamide by 2-[-2-cyanaziridinyl-(1)-]-2-[-2-carbamoylaziridinyl-(1)]-propane BM 12 531. | 1978 |
|
| Modulation in vitro of immune parameters in homosexual males with the preclinical complex of symptoms related to acquired immune deficiency syndrome by azimexon. | 1986 Jun |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 17:14:52 GMT 2023
by
admin
on
Sat Dec 16 17:14:52 GMT 2023
|
| Record UNII |
4NJ842U6BZ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C797
Created by
admin on Sat Dec 16 17:14:52 GMT 2023 , Edited by admin on Sat Dec 16 17:14:52 GMT 2023
|
||
|
NCI_THESAURUS |
C2139
Created by
admin on Sat Dec 16 17:14:52 GMT 2023 , Edited by admin on Sat Dec 16 17:14:52 GMT 2023
|
||
|
NCI_THESAURUS |
C2080
Created by
admin on Sat Dec 16 17:14:52 GMT 2023 , Edited by admin on Sat Dec 16 17:14:52 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C1347
Created by
admin on Sat Dec 16 17:14:52 GMT 2023 , Edited by admin on Sat Dec 16 17:14:52 GMT 2023
|
PRIMARY | |||
|
264-679-7
Created by
admin on Sat Dec 16 17:14:52 GMT 2023 , Edited by admin on Sat Dec 16 17:14:52 GMT 2023
|
PRIMARY | |||
|
CHEMBL149579
Created by
admin on Sat Dec 16 17:14:52 GMT 2023 , Edited by admin on Sat Dec 16 17:14:52 GMT 2023
|
PRIMARY | |||
|
4NJ842U6BZ
Created by
admin on Sat Dec 16 17:14:52 GMT 2023 , Edited by admin on Sat Dec 16 17:14:52 GMT 2023
|
PRIMARY | |||
|
4546
Created by
admin on Sat Dec 16 17:14:52 GMT 2023 , Edited by admin on Sat Dec 16 17:14:52 GMT 2023
|
PRIMARY | |||
|
SUB05656MIG
Created by
admin on Sat Dec 16 17:14:52 GMT 2023 , Edited by admin on Sat Dec 16 17:14:52 GMT 2023
|
PRIMARY | |||
|
DTXSID60867055
Created by
admin on Sat Dec 16 17:14:52 GMT 2023 , Edited by admin on Sat Dec 16 17:14:52 GMT 2023
|
PRIMARY | |||
|
47294
Created by
admin on Sat Dec 16 17:14:52 GMT 2023 , Edited by admin on Sat Dec 16 17:14:52 GMT 2023
|
PRIMARY | |||
|
64118-86-1
Created by
admin on Sat Dec 16 17:14:52 GMT 2023 , Edited by admin on Sat Dec 16 17:14:52 GMT 2023
|
PRIMARY | |||
|
100000086084
Created by
admin on Sat Dec 16 17:14:52 GMT 2023 , Edited by admin on Sat Dec 16 17:14:52 GMT 2023
|
PRIMARY | |||
|
C016866
Created by
admin on Sat Dec 16 17:14:52 GMT 2023 , Edited by admin on Sat Dec 16 17:14:52 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
